Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial

Constipation is a major issue for 10–20% of the global population. In a double-blind randomized placebo-controlled clinical trial, we aimed to determine a dose-response effect of galacto-oligosaccharides (GOS) on stool characteristics and fecal microbiota in 132 adults with self-reported constipatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoemaker, Marieke H., Hageman, Jeske H. J., ten Haaf, Dominique, Hartog, Anita, Scholtens, Petra A. M. J., Boekhorst, Jos, Nauta, Arjen, Bos, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780623/
https://www.ncbi.nlm.nih.gov/pubmed/35057489
http://dx.doi.org/10.3390/nu14020309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780623/
https://www.ncbi.nlm.nih.gov/pubmed/35057489
http://dx.doi.org/10.3390/nu14020309

Ejemplares similares